A Dynamic Model of HIV Integrase Inhibition and Drug Resistance
- 22 January 2010
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 397 (2) , 600-615
- https://doi.org/10.1016/j.jmb.2010.01.033
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In VivoAntimicrobial Agents and Chemotherapy, 2010
- Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic FailureAntimicrobial Agents and Chemotherapy, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutationNucleic Acids Research, 2008
- Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type 1 IntegraseJournal of Virology, 2008
- An improved relaxed complex scheme for receptor flexibility in computer-aided drug designJournal of Computer-Aided Molecular Design, 2008
- In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediateRetrovirology, 2007
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins-Structure Function and Bioinformatics, 2006
- Molecular dynamics studies of the full-length integrase–DNA complexBiochemical and Biophysical Research Communications, 2005
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983